To evaluate the loss of Keap1 and its effects on Nrf2 overexpression and cellular localization in primary HNSCC tumors, we immunoassayed Nrf2 expression using the anti-Nrf2 antibody in HNSCC primary tumor tissues. This evidence concerns the gene KEAP1 and neoplasm.